Preclinical hazard evaluation strategy for nanomedicines

References

• Aderem, A. 2003. “Phagocytosis and the Inflammatory Response.” The Journal of Infectious Diseases 187 (s2): S340–S345. doi:10.1086/374747
   PubMedGoogle Scholar
• Aguilar-Castillo, B. A., J. L. Santos, H. Luo, Y. E. Aguirre-Chagala, T. Palacios-Hernandez, and M. Herrera-Alonso. 2015. “Nanoparticle Stability in Biologically Relevant Media: influence of Polymer Architecture.” Soft Matter 11 (37): 7296–7307. doi:10.1039/C5SM01455G
   PubMed Web of Science ®Google Scholar
• Ahrens, N., L. Schewior, E. Garbe, H. Kiesewetter, and A. Salama. 2004. “Massive Haemolysis after Intramuscular Diclofenac in a Patient Who Apparently Tolerated Oral Medication.” Vox Sanguinis 86 (1): 71–74. doi:10.1111/j.0042-9007.2004.00389.x
   PubMed Web of Science ®Google Scholar
• Akthakul, A., A. I. Hochbaum, F. Stellacci, and A. M. Mayes. 2005. “Size Fractionation of Metal Nanoparticles by Membrane Filtration.” Advanced Materials 17 (5): 532–535. doi:10.1002/adma.200400636
   Web of Science ®Google Scholar
• Álvarez-Fuentes, J., L. Martín-Banderas, I. Muñoz-Rubio, M. A. Holgado, and M. Fernández-Arévalo. 2012. “Development and Validation of an RP-HPLC Method for CB13 Evaluation in Several PLGA Nanoparticle Systems [WWW Document].” The Scientific World Journal 2012: 737526. doi:10.1100/2012/737526
   Google Scholar
• Ambrogio, M. W., C. R. Thomas, Y.-L. Zhao, J. I. Zink, and J. F. Stoddart. 2011. “Mechanized Silica Nanoparticles: A New Frontier in Theranostic Nanomedicine.” Accounts of Chemical Research 44 (10): 903–913. doi:10.1021/ar200018x
   PubMed Web of Science ®Google Scholar
• Amenabar, I., S. Poly, W. Nuansing, E. H. Hubrich, A. A. Govyadinov, F. Huth, R. Krutokhvostov, L. Zhang, M. Knez, J. Heberle. J., et al. 2013. “Structural Analysis and Mapping of Individual Protein Complexes by Infrared Nanospectroscopy.” Nature Communications 4 (1): 3890. Ncomms doi:10.1038/ncomms3890
   Google Scholar
• Amidon, G. L., H. Lennernäs, V. P. Shah, and J. R. Crison. 1995. “A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability.” Pharmaceutical Research 12: 413–420. doi:10.1023/A:1016212804288
   PubMed Web of Science ®Google Scholar
• Ankley, G. T., R. S. Bennett, R. J. Erickson, D. J. Hoff, M. W. Hornung, R. D. Johnson, D. R. Mount, J. W. Nichols, C. L. Russom, P. K. Schmieder, et al. 2010. “Adverse Outcome Pathways: A Conceptual Framework to Support Ecotoxicology Research and Risk Assessment.” Environmental Toxicology and Chemistry 29 (3): 730–741. doi:10.1002/etc.34
   PubMed Web of Science ®Google Scholar
• Arap, W., R. Pasqualini, M. Montalti, L. Petrizza, L. Prodi, E. Rampazzo, N. Zaccheroni, and S. Marchiò. 2013. “Luminescent Silica Nanoparticles for Cancer Diagnosis.” Current Medicinal Chemistry 20 (17): 2195–2211. doi:10.2174/0929867311320170005
   PubMed Web of Science ®Google Scholar
• Arts, J. H. E., M. Hadi, M.-A. Irfan, A. M. Keene, R. Kreiling, D. Lyon, M. Maier, K. Michel, T. Petry, U. G. Sauer, et al. 2015a. “A Decision-Making Framework for the Grouping and Testing of Nanomaterials (DF4nanoGrouping).” Regulatory Toxicology and Pharmacology 71 (2): S1–S27. doi:10.1016/j.yrtph.2015.03.007
   PubMed Web of Science ®Google Scholar
• Atkinson, P. M., D. I. Taylor, and N. Chetty. 1985. “Inhibition of Platelet Aggregation by Ketamine Hydrochloride.” Thrombosis Research 40 (2): 227–234. doi:10.1016/0049-3848(85)90333-0
   PubMed Web of Science ®Google Scholar
• Bao, H., X. Yu, C. Xu, X. Li, Z. Li, D. Wei, and Y. Liu. 2015. “New Toxicity Mechanism of Silver Nanoparticles: Promoting Apoptosis and Inhibiting Proliferation.” PLoS One 10 (3): e0122535. doi:10.1371/journal.pone.0122535
   PubMed Web of Science ®Google Scholar
• Bartneck, M., H. A. Keul, S. Singh, K. Czaja, J. Bornemann, M. Bockstaller, M. Moeller, G. Zwadlo-Klarwasser, and J. Groll. 2010a. “Rapid Uptake of Gold Nanorods by Primary Human Blood Phagocytes and Immunomodulatory Effects of Surface Chemistry.” ACS Nano 4 (6): 3073–3086. doi:10.1021/nn100262h
   PubMed Web of Science ®Google Scholar
• Bartneck, M., H. A. Keul, G. Zwadlo-Klarwasser, and J. Groll. 2010b. “Phagocytosis Independent Extracellular Nanoparticle Clearance by Human Immune Cells.” Nano Letters 10 (1): 59–63. doi:10.1021/nl902830x
   PubMed Web of Science ®Google Scholar
• Berg, J. M., A. Romoser, N. Banerjee, R. Zebda, and C. M. Sayes. 2009. “The Relationship between pH and Zeta Potential of ∼30 Nm Metal Oxide Nanoparticle Suspensions Relevant to in Vitro Toxicological Evaluations.” Nanotoxicology 3 (4): 276–283. doi:10.3109/17435390903276941
   Web of Science ®Google Scholar
• Berger, M. 2009. “Size matters. Comparing the toxicity of micro- to nanoparticles” [WWW Document]. Accessed August 21 2017. http://www.nanowerk.com/spotlight/spotid=10128.php
   Google Scholar
• Bhattacharjee, S. 2016. “DLS and Zeta Potential – What They Are and What They Are Not?.” Journal of Controlled Release 235: 337–351. doi:10.1016/j.jconrel.2016.06.017
   PubMed Web of Science ®Google Scholar
• Bleeker, E. A. J., W. H. de Jong, R. E. Geertsma, M. Groenewold, E. H. W. Heugens, M. Koers-Jacquemijns, D. van de Meent, J. R. Popma, A. G. Rietveld, S. W. P. Wijnhoven, et al. 2013. “Considerations on the EU Definition of a Nanomaterial: Science to Support Policy Making.” Regulatory Toxicology and Pharmacology 65 (1): 119–125. doi:10.1016/j.yrtph.2012.11.007
   PubMed Web of Science ®Google Scholar
• Bobo, D., K. J. Robinson, J. Islam, K. J. Thurecht, and S. R. Corrie. 2016. “Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.” Pharmaceutical Research 33 (10): 2373–2387. doi:10.1007/s11095-016-1958-5
   PubMed Web of Science ®Google Scholar
• Boilard, S. P., P. R. Amyotte, F. I. Khan, A. G. Dastidar, and R. K. Eckhoff. 2013. “Explosibility of Micron- and Nano-Size Titanium Powders.” Journal of Loss Prevention in the Process Industries 26 (6): 1646–1654. doi:10.1016/j.jlp.2013.06.003
   Web of Science ®Google Scholar
• Bolt, H. M. 2014. “Grouping of Nanomaterials for Risk Assessment.” Archives of Toxicology 88 (12): 2077–2078. doi:10.1007/s00204-014-1416-2
   PubMed Web of Science ®Google Scholar
• Bozzuto, G., and A. Molinari. 2015. “Liposomes as Nanomedical Devices.” International Journal of Nanomedicine 10: 975–999. doi10.2147/IJN.S68861
   PubMed Web of Science ®Google Scholar
• Brown, J. S., T. Gordon, O. Price, and B. Asgharian. 2013. “Thoracic and Respirable Particle Definitions for Human Health Risk Assessment.” Particle and Fibre Toxicology 10 (1): 12. doi:10.1186/1743-8977-10-12
   PubMedGoogle Scholar
• Buzea, C., I. I. Pacheco, and K. Robbie. 2007. “Nanomaterials and Nanoparticles: sources and Toxicity.” Biointerphases 2 (4): MR17–MR71. doi:10.1116/1.2815690
   PubMed Web of Science ®Google Scholar
• Casals, E., T. Pfaller, A. Duschl, G. J. Oostingh, and V. Puntes. 2010. “Time Evolution of the Nanoparticle Protein Corona.” ACS Nano 4 (7): 3623–3632. doi:10.1021/nn901372t
   PubMed Web of Science ®Google Scholar
• Champion, J. A., Y. K. Katare, and S. Mitragotri. 2007. “Particle Shape: A New Design Parameter for Micro- and Nanoscale Drug Delivery Carriers.” Official journal of the Controlled Release Society 121 (1–2): 3–9. doi:10.1016/j.jconrel.2007.03.022
   PubMed Web of Science ®Google Scholar
• Chen, F., G. Wang, J. I. Griffin, B. Brenneman, N. K. Banda, V. M. Holers, D. S. Backos, L. Wu, S. M. Moghimi, and D. Simberg. 2017. “Complement Proteins Bind to Nanoparticle Protein Corona and Undergo Dynamic Exchange In Vivo.” Nature Nanotechnology 12 (4): 387–393. doi:10.1038/nnano.2016.269
   PubMed Web of Science ®Google Scholar
• Chukwuocha, E. O., M. C. Onyeaju, and T. S. T. Harry. 2012. “Theoretical Studies on the Effect of Confinement on Quantum Dots Using the Brus Equation World Journal of Condensed Matter Physics 2 (2): 96–100. doi:10.4236/wjcmp.2012.22017
   Google Scholar
• Cicha, I. 2016. “Strategies to Enhance Nanoparticle-Endothelial Interactions under Flow.” Journal of Cellular Biotechnology 1 (2): 191–208. doi:10.3233/JCB-15020
   Google Scholar
• Clogston, J. D., and A. K. Patri. 2011. “Zeta Potential Measurement.” Methods in Molecular Biology (Clifton, N.J.) 697: 63–70. doi:10.1007/978-1-60327-198-1
   PubMedGoogle Scholar
• Coti, K. K., M. E. Belowich, M. Liong, M. W. Ambrogio, Y. A. Lau, H. A. Khatib, J. I. Zink, N. M. Khashab, and J. F. Stoddart. 2009. “Mechanised Nanoparticles for Drug Delivery.” Nanoscale 1 (1): 16–39. doi:10.1039/b9nr00162j
   PubMed Web of Science ®Google Scholar
• Crawford, R., B. Dogdas, E. Keough, R. M. Haas, W. Wepukhulu, S. Krotzer, P. A. Burke, L. Sepp-Lorenzino, A. Bagchi, and B. J. Howell. 2011. “Analysis of Lipid Nanoparticles by Cryo-EM for Characterizing siRNA Delivery Vehicles.” International Journal of Pharmaceutics 403 (1–2): 237–44. doi:10.1016/j.ijpharm.2010.10.025
   PubMed Web of Science ®Google Scholar
• Davignon, J., and P. Ganz. 2004. “Role of Endothelial Dysfunction in Atherosclerosis.” Circulation 109 (23_suppl_1): III-27–III-32. doi:10.1161/01.CIR.0000131515.03336.f8
   Web of Science ®Google Scholar
• Deanfield, J., A. Donald, C. Ferri, C. Giannattasio, J. Halcox, S. Halligan, A. Lerman, G. Mancia, J. J. Oliver, A. C. Pessina, et al., Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. 2005. “Endothelial Function and Dysfunction. Part I: Methodological Issues for Assessment in the Different Vascular Beds: A Statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension.” Journal of Hypertension 23 (1): 7–17. doi:10.1097/00004872-200501000-00004
   PubMed Web of Science ®Google Scholar
• Dekkers, S., A. G. Oomen, E. A. J. Bleeker, R. J. Vandebriel, C. Micheletti, J. Cabellos, G. Janer, N. Fuentes, S. Vázquez-Campos, T. Borges, et al. 2016. “Towards a Nanospecific Approach for Risk Assessment.” Regulatory Toxicology and Pharmacology 80: 46–59. doi:10.1016/j.yrtph.2016.05.037
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia, M. A., A. K. Patri, J. Simak, J. B. Hall, J. Semberova, S. H. De Paoli Lacerda, and S. E. McNeil. 2012. “Nanoparticle Size and Surface Charge Determine Effects of PAMAM Dendrimers on Human Platelets in Vitro.” Molecular Pharmaceutics 9 (3): 382–393. doi:10.1021/mp200463e
   PubMed Web of Science ®Google Scholar
• Docter, D., D. Westmeier, M. Markiewicz, S. Stolte, S. K. Knauer, and R. H. Stauber. 2015. “The Nanoparticle Biomolecule Corona: lessons Learned – Challenge Accepted?” Chemical Society Reviews 44: 6094–6121. doi:10.1039/C5CS00217F
   PubMed Web of Science ®Google Scholar
• Dongargaonkar, A. A., and J. D. Clogston. 2018. “Quantitation of Surface Coating on Nanoparticles Using Thermogravimetric Analysis.” In Characterization of Nanoparticles Intended for Drug Delivery, Methods in Molecular Biology, edited by McNeil S, 57–63. New York, NY: Humana Press. doi:10.1007/978-1-4939-7352-1_6
   Google Scholar
• Droppo, I. G. 2006. “Filtration in Particle Size Analysis.” In Encyclopedia of Analytical Chemistry, edited by R. A. Meyers and R. B. Flippen. Hoboken, New Jersey: John Wiley & Sons, Ltd. doi:10.1002/9780470027318.a1506
   Google Scholar
• Dusinska, M., M. Dusinska, L. Fjellsbø, Z. Magdolenova, A. Rinna, E. Runden Pran, A. Bartonova, E. Heimstad, M. Harju, L. Tran. et al. 2009. “Testing Strategies for the Safety of Nanoparticles Used in Medical Applications.” Nanomed 4 (6): 605–607. doi:10.2217/nnm.09.47
   PubMed Web of Science ®Google Scholar
• ECHA. 2013. “Grouping of Substances and Read-Across – ECHA” [WWW Document]. Accessed August 28 2017. https://echa.europa.eu/support/registration/how-to-avoid-unnecessary-testing-on-animals/grouping-of-substances-and-read-across
   Google Scholar
• Elgqvist, J. 2017. “Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer.” International Journal of Molecular Sciences 18 (5): 1102. doi:10.3390/ijms18051102
   Web of Science ®Google Scholar
• Ermidou-Pollet, S., H. Nounopoulos, N. Sdougas, M. Szilágyi, and S. Pollet. 2005. “Influence of Subcutaneous Injection of Essential Fatty Acids on the Stress-Induced Modifications of Rat Platelet Aggregation and Membrane Lipid Composition.” Acta Biologica Hungarica 56 (3–4): 247–259. doi:10.1556/ABiol.56.2005.3-4.8
   PubMed Web of Science ®Google Scholar
• Etheridge, M. L., S. A. Campbell, A. G. Erdman, C. L. Haynes, S. M. Wolf, and J. McCullough. 2013. “The Big Picture on Small Medicine: The State of Nanomedicine Products Approved for Use or in Clinical Trials.” Nanomedicine: Nanotechnology, Biology, and Medicine 9 (1): 1–14. doi:10.1016/j.nano.2012.05.013
   PubMed Web of Science ®Google Scholar
• European Medicines Agency - Multidisciplinary - Data requirements for intravenous iron-based nano-colloidal products developed with reference to an innovator medicinal product [WWW Document], n.d. Accessed January 19 2018. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/03/WC500184922.pdf
   Google Scholar
• European Medicines Agency - Multidisciplinary - Joint MHLW/EMA reflection paper on the development of block copolymer micelle medicinal products [WWW Document], n.d. Accessed January 19 2018. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/02/WC500138390.pdf
   Google Scholar
• European Medicines Agency - Multidisciplinary - Reflection paper on surface coatings: general issues for consideration regarding parenteral administration of coated nanomedicine products [WWW Document], n.d. Accessed January 19 2018. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/08/WC500147874.pdf
   Google Scholar
• European Medicines Agency - Multidisciplinary - Reflection paper on the data requirements for intravenous liposomal products developed with reference to an innovator liposomal product [WWW Document], n.d. Accessed January 19 2018. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/03/WC500140351.pdf
   Google Scholar
• European Medicines Agency - Multidisciplinary - Reflection paper on nanotechnology-based medicinal products for human use [WWW Document], n.d. Accessed 19 Jan 2018. http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2010/01/WC500069728.pdf
   Google Scholar
• Fabricius, A.-L., L. Duester, B. Meermann, and T. A. Ternes. 2014. “ICP-MS-Based Characterization of Inorganic Nanoparticles—Sample Preparation and off-Line Fractionation Strategies.” Analytical and Bioanalytical Chemistry 406 (2): 467–479. doi:10.1007/s00216-013-7480-2
   PubMed Web of Science ®Google Scholar
• Fadeel, B. 2012. Clear and Present Danger? Engineered Nanoparticles and the Immune System [WWW document]. Swiss Med. Wkly. Accessed May 11 2016. http://blog.smw.ch/
   Google Scholar
• Fadeel, B., A. Pietroiusti, and A. A. Shvedova. 2017. Adverse Effects of Engineered Nanomaterials: Exposure, Toxicology, and Impact on Human Health. Cambridge, Massachusetts: Academic Press.
   Google Scholar
• FDA. 2005. “Guidance for Industry on Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers.” Availability [WWW Document]. Fed. Regist. Accessed August 24 2017. https://www.federalregister.gov/documents/2005/07/22/05-14456/guidance-for-industry-on-estimating-the-maximum-safe-starting-dose-in-initial-clinical-trials-for
   Google Scholar
• Félétou, M. 2011. “The Endothelium: Part 1: Multiple Functions of the Endothelial Cells—Focus on Endothelium-Derived Vasoactive Mediators.” In Integrated Systems Physiology: From Molecule to Function to Disease, edited by D. Neil Granger and Joey P. Granger, 1–306. San Rafael (CA): Morgan & Claypool Life Sciences.
   Google Scholar
• Feliu, N., and B. Fadeel. 2010. “Nanotoxicology: No Small Matter.” Nanoscale 2 (12): 2514–2520. doi:10.1039/c0nr00535e
   PubMed Web of Science ®Google Scholar
• Friedrich, R. P., C. Janko, M. Poettler, P. Tripal, J. Zaloga, I. Cicha, S. Dürr, J. Nowak, S. Odenbach, I. Slabu. et al. 2015. “Flow Cytometry for Intracellular SPION Quantification: Specificity and Sensitivity in Comparison with Spectroscopic Methods.” International Journal of Nanomedicine 10: 4185–4201. doi:10.2147/IJN.S82714
   PubMed Web of Science ®Google Scholar
• Fröhlich, E. 2017. “Role of Omics Techniques in the Toxicity Testing of Nanoparticles.” Journal of Nanobiotechnology 15 (1): 84. doi:10.1186/s12951-017-0320-3
   PubMedGoogle Scholar
• Fubini, B., M. Ghiazza, and I. Fenoglio. 2010. “Physico-Chemical Features of Engineered Nanoparticles Relevant to Their Toxicity.” Nanotoxicology 4 (4): 347–363. doi:10.3109/17435390.2010.509519
   PubMed Web of Science ®Google Scholar
• Gallud, A., and B. Fadeel. 2015. “Keeping It Small: Towards a Molecular Definition of Nanotoxicology.” European Journal of Nanomedicine 7: 143–151. doi:10.1515/ejnm-2015-0020
   Web of Science ®Google Scholar
• Garbovskiy, Y. 2017. “Biological Contamination of Nanoparticles and Its Manifestation in Optical Absorbance Measurements.” Analytical Chemistry 89 (14): 7282–7285. doi:10.1021/acs.analchem.7b01766
   PubMed Web of Science ®Google Scholar
• Gebel, T., H. Foth, G. Damm, A. Freyberger, P.-J. Kramer, W. Lilienblum, C. Röhl, T. Schupp, C. Weiss, K.-M. Wollin, et al. 2014. “Manufactured Nanomaterials: Categorization and Approaches to Hazard Assessment.” Archives of Toxicology 88 (12): 2191–2211. doi:10.1007/s00204-014-1383-7
   PubMed Web of Science ®Google Scholar
• Goldstein, A., Y. Soroka, M. Frušić-Zlotkin, I. Popov, and R. Kohen. 2014. “High Resolution SEM Imaging of Gold Nanoparticles in Cells and Tissues.” Journal of Microscopy 256 (3): 237–247. doi:10.1111/jmi.12179
   PubMed Web of Science ®Google Scholar
• Gottardo, S. 2017. “NANoREG Framework for the Safety Assessment of Nanomaterials - EU Science Hub - European Commission [WWW Document].” EU Science Hub. Accessed March 7 2018. https://ec.europa.eu/jrc/en/publication/eur-scientific-and-technical-research-reports/nanoreg-framework-safety-assessment-nanomaterials
   Google Scholar
• Gregoriadis, G., 1985. Liposomes for drugs and vaccines. Trends Biotechnol. 3: 235–241. doi:10.1016/0167-7799(85)90014-9
   Web of Science ®Google Scholar
• Gregory, A. E., R. Titball, and D. Williamson. 2013. “Vaccine Delivery Using Nanoparticles.” Frontiers in Cellular and Infection Microbiology 3: 13. doi:10.3389/fcimb.2013.00013
   PubMed Web of Science ®Google Scholar
• Guadagnini, R., B. Halamoda Kenzaoui, L. Walker, G. Pojana, Z. Magdolenova, D. Bilanicova, M. Saunders, L. Juillerat-Jeanneret, A. Marcomini, A. Huk, et al. 2015. “Toxicity Screenings of Nanomaterials: Challenges Due to Interference with Assay Processes and Components of Classic in Vitro Tests.” Nanotoxicology 9 (Supp1): 13–24. doi:10.3109/17435390.2013.829590
   PubMedGoogle Scholar
• Guarnieri, D., S. Sabella, O. Muscetti, V. Belli, M. A. Malvindi, S. Fusco, E. De Luca, P. P. Pompa, and P. A. Netti. 2014. “Transport across the Cell-Membrane Dictates Nanoparticle Fate and Toxicity: A New Paradigm in Nanotoxicology.” Nanoscale 6 (17): 10264–10273. doi:10.1039/C4NR02008A
   PubMed Web of Science ®Google Scholar
• Guha, S., M. Li, M. J. Tarlov, and M. R. Zachariah. 2012. “Electrospray–Differential Mobility Analysis of Bionanoparticles.” Trends Biotechnol 30 (5): 291–300. doi:10.1016/j.tibtech.2012.02.003
   PubMed Web of Science ®Google Scholar
• Guo, C., Y. Xia, P. Niu, L. Jiang, J. Duan, Y. Yu, X. Zhou, Y. Li, and Z. Sun. 2015. “Silica Nanoparticles Induce Oxidative Stress, Inflammation, and Endothelial Dysfunction in Vitro via Activation of the MAPK/Nrf2 Pathway and Nuclear Factor-κB Signaling.” International Journal of Nanomedicine 10: 1463–1477. doi:10.2147/IJN.S76114
   PubMed Web of Science ®Google Scholar
• Guo, C., and J. L. Yarger. 2018. “Characterizing Gold Nanoparticles by NMR Spectroscopy.” Magnetic Resonance in Chemistry. doi:10.1002/mrc.4753. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Hackley, V. A., and J. D. Clogston. 2011. “Measuring the Hydrodynamic Size of Nanoparticles in Aqueous Media Using Batch-Mode Dynamic Light Scattering.” In Characterization of Nanoparticles Intended for Drug Delivery, edited by S. E. McNeil, 35–52. Totowa, NJ: Humana Press. doi:10.1007/978-1-60327-198-1_4
   Google Scholar
• Hadrup, N., A. K. Sharma, M. Poulsen, and E. Nielsen. 2015. “Toxicological Risk Assessment of Elemental Gold following Oral Exposure to Sheets and Nanoparticles - A Review.” Regulatory Toxicology and Pharmacology 72 (2): 216–221. doi:10.1016/j.yrtph.2015.04.017
   PubMed Web of Science ®Google Scholar
• Hole, P., K. Sillence, C. Hannell, C. M. Maguire, M. Roesslein, G. Suarez, S. Capracotta, Z. Magdolenova, L. Horev-Azaria, A. Dybowska, et al. 2013. “Interlaboratory Comparison of Size Measurements on Nanoparticles Using Nanoparticle Tracking Analysis (NTA).” Journal of Nanoparticle Research 15 (12): 2101. doi:10.1007/s11051-013-2101-8
   PubMed Web of Science ®Google Scholar
• Hung, H.-I., O. J. Klein, S. W. Peterson, S. R. Rokosh, S. Osseiran, N. H. Nowell, and C. L. Evans. 2016. “PLGA Nanoparticle Encapsulation Reduces Toxicity While Retaining the Therapeutic Efficacy of EtNBS-PDT In Vitro.” Scientific Reports 6 (1): 33234. doi:10.1038/srep33234
   PubMedGoogle Scholar
• Huth, F., A. Govyadinov, S. Amarie, W. Nuansing, F. Keilmann, and R. Hillenbrand. 2012. “Nano-FTIR Absorption Spectroscopy of Molecular Fingerprints at 20 Nm Spatial Resolution.” Nano Letters 12 (8): 3973–3978. doi:10.1021/nl301159v
   PubMed Web of Science ®Google Scholar
• ISO. 2015. “ISO/TS 80004-2:2015(en), Nanotechnologies — Vocabulary — Part 2: Nano-objects.” [WWW Document]. Accessed August 28 2017. https://www.iso.org/obp/ui/#iso:std:iso:ts:80004:-2:ed-1:v1:en
   Google Scholar
• Itoh, N., E. Yamamoto, T. Santa, T. Funatsu, and M. Kato. 2016. “Effect of Nanoparticle Surface on the HPLC Elution Profile of Liposomal Nanoparticles.” Pharmaceutical Research 33 (6): 1440–1446. doi:10.1007/s11095-016-1886-4
   PubMed Web of Science ®Google Scholar
• Jarockyte, G., E. Daugelaite, M. Stasys, U. Statkute, V. Poderys, T.-C. Tseng, S.-H. Hsu, V. Karabanovas, and R. Rotomskis. 2016. “Accumulation and Toxicity of Superparamagnetic Iron Oxide Nanoparticles in Cells and Experimental Animals.” International Journal of Molecular Sciences 17 (8): 1193. doi:10.3390/ijms17081193
   PubMed Web of Science ®Google Scholar
• Jong, W. 2010. “Scientific Basis for the Definition of the Term ‘nanomaterial’.” [WWW Document] Accessed 28 August 2017. http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_032.pdf
   Google Scholar
• Joris, F., D. Valdepérez, B. Pelaz, S. J. Soenen, B. B. Manshian, W. J. Parak, S. C. De Smedt, and K. Raemdonck. 2016. “The Impact of Species and Cell Type on the Nanosafety Profile of Iron Oxide Nanoparticles in Neural Cells.” Journal of Nanobiotechnology 14 (1): 69. doi:10.1186/s12951-016-0220-y
   PubMedGoogle Scholar
• Junghanns, J.-U. A. H., and R. H. Müller. 2008. “Nanocrystal Technology, Drug Delivery and Clinical Applications.” International Journal of Nanomedicine 3 (3): 295–310.
   PubMed Web of Science ®Google Scholar
• Kaszuba, M., D. McKnight, M. T. Connah, F. K. McNeil-Watson, and U. Nobbmann. 2008. “Measuring Sub Nanometre Sizes Using Dynamic Light Scattering.” Journal of Nanoparticle Research 10 (5): 823–829. doi:10.1007/s11051-007-9317-4
   Web of Science ®Google Scholar
• Ke, P. C., S. Lin, W. J. Parak, T. P. Davis, and F. Caruso. 2017. “A Decade of the Protein Corona.” ACS Nano 11 (12): 11773–11776. doi:10.1021/acsnano.7b08008
   PubMed Web of Science ®Google Scholar
• Kennedy, I. M., D. Wilson, and A. I. Barakat; HEI Health Review Committee. 2009. “Uptake and Inflammatory Effects of Nanoparticles in a Human Vascular Endothelial Cell Line.” Research reports - Health Effects Institute 136: 3–32.
   Google Scholar
• Kettiger, H., A. Schipanski, P. Wick, and J. Huwyler. 2013. “Engineered Nanomaterial Uptake and Tissue Distribution: From Cell to Organism.” International Journal of Nanomedicine 8: 3255–3269. doi:10.2147/IJN.S49770
   PubMed Web of Science ®Google Scholar
• Kievit, F. M., and M. Zhang. 2011. “Surface Engineering of Iron Oxide Nanoparticles for Targeted Cancer Therapy.” Accounts of Chemical Research 44 (10): 853–862. doi:10.1021/ar2000277
   PubMed Web of Science ®Google Scholar
• Kim, I.-Y., E. Joachim, H. Choi, and K. Kim. 2015. “Toxicity of Silica Nanoparticles Depends on Size, Dose, and Cell Type.” Nanomedicine: Nanotechnology, Biology, and Medicine 11 (6): 1407–1416. doi:10.1016/j.nano.2015.03.004
   PubMed Web of Science ®Google Scholar
• Krug, H. F. 2014. “Nanosafety Research – Are We On the Right Track?” Angewandte Chemie (International Ed. In English) 53 (46): 12304–12319. doi:10.1002/anie.201403367
   PubMed Web of Science ®Google Scholar
• Krug, H. F., and P. Wick. 2011. “Nanotoxicology: An Interdisciplinary Challenge.” Angewandte Chemie International Edition 50 (6): 1260–1278. doi:10.1002/anie.201001037
   PubMed Web of Science ®Google Scholar
• Laux, P., C. Riebeling, A. M. Booth, J. D. Brain, J. Brunner, C. Cerrillo, O. Creutzenberg, I. Estrela-Lopis, T. Gebel, G. Johanson, et al. 2017. “Biokinetics of Nanomaterials: The Role of Biopersistence.” NanoImpact 6: 69–80. doi:10.1016/j.impact.2017.03.003
   PubMed Web of Science ®Google Scholar
• Lee, J. H., Y. S. Kim, K. S. Song, H. R. Ryu, J. H. Sung, J. D. Park, H. M. Park, N. W. Song, B. S. Shin, D. Marshak, et al. 2013. “Biopersistence of Silver Nanoparticles in Tissues from Sprague–Dawley Rats.” Particle and Fibre Toxicology 10 (1): 36. doi:10.1186/1743-8977-10-36
   PubMedGoogle Scholar
• Li, L. K. Y. Mak, J. Shi, C. H. Leung, C. M. Wong, C. W. Leung, C. S. K. Mak, K. Y. Chan, N. M. M. Chan, E. X. Wu, and P. W. T. Pong. 2013. “Sterilization on Dextran-Coated Iron Oxide Nanoparticles: Effects of Autoclaving, Filtration, UV Irradiation, and Ethanol Treatment.” Microelectronic Engineering 111: 310–313. doi:10.1016/j.mee.2013.02.021
   Web of Science ®Google Scholar
• Li, T., A. J. Senesi, and B. Lee. 2016. “Small Angle X-Ray Scattering for Nanoparticle Research.” Chemical Reviews 116 (18): 11128–11180. doi:10.1021/acs.chemrev.5b00690
   PubMed Web of Science ®Google Scholar
• Li, Y., and D. Boraschi. 2016. “Endotoxin Contamination: A Key Element in the Interpretation of Nanosafety Studies.” Nanomed 11 (3): 269–287. doi:10.2217/nnm.15.196
   PubMed Web of Science ®Google Scholar
• Li, Z., Y. Zhang, D. Zhu, S. Li, X. Yu, Y. Zhao, X. Ouyang, Z. Xie, and L. Li. 2017. “Transporting Carriers for Intracellular Targeting Delivery via Non-Endocytic Uptake Pathways.” Drug Delivery 24 (2): 45–55. doi:10.1080/10717544.2017.1391889
   PubMed Web of Science ®Google Scholar
• Lovestam, G. 2010. “Considerations on a Definition of Nanomaterial for Regulatory Purposes.” [WWW Document]. Accessed 28 August 2017. https://ec.europa.eu/jrc/sites/jrcsh/files/jrc_reference_report_201
   Google Scholar
• Lu, M., M. H. Cohen, D. Rieves, and R. Pazdur. 2010. “FDA Report: Ferumoxytol for Intravenous Iron Therapy in Adult Patients with Chronic Kidney Disease.” American Journal of Hematology 85 (5): 315–319. doi:10.1002/ajh.21656
   PubMed Web of Science ®Google Scholar
• Maguire, C. M., Sillence, K. Roesslein, M. Hannell, C. Suarez, G. Sauvain, J.-J. Capracotta, S. Contal, S. Cambier, S. El Yamani. N. et al., 2017. “Benchmark of Nanoparticle Tracking Analysis on Measuring Nanoparticle Sizing and Concentration.” Journal of Micro and Nano-Manufacturing 5 (4): 041002–041010. doi:10.1115/1.4037124
   Web of Science ®Google Scholar
• Mahmoudi, M., H. Hofmann, B. Rothen-Rutishauser, and A. Petri-Fink. 2012. “Assessing the in Vitro and in Vivo Toxicity of Superparamagnetic Iron Oxide Nanoparticles.” Chemical Reviews 112 (4): 2323–2338. doi:10.1021/cr2002596
   PubMed Web of Science ®Google Scholar
• Mansfield, E., K. M. Tyner, C. M. Poling, and J. L. Blacklock. 2014. “Determination of Nanoparticle Surface Coatings and Nanoparticle Purity Using Microscale Thermogravimetric Analysis.” Analytical Chemistry 86: 1478–1484. doi:10.1021/ac402888v
   PubMed Web of Science ®Google Scholar
• McCormack, P. L. 2012. “Ferumoxytol: In Iron Deficiency Anaemia in Adults with Chronic Kidney Disease.” Drugs 72: 2013–2022. doi:10.2165/11209880-000000000-00000
   PubMed Web of Science ®Google Scholar
• Mehn, D., F. Caputo, M. Rösslein, L. Calzolai, F. Saint-Antonin, T. Courant, P. Wick, and D. Gilliland. 2017. “Larger or More? Nanoparticle Characterisation Methods for Recognition of Dimers.” RSC Advances 7 (44): 27747–27754. doi:10.1039/C7RA02432K
   Web of Science ®Google Scholar
• Meng, J., M. Yang, F. Jia, Z. Xu, H. Kong, and H. Xu. 2011. “Immune Responses of BALB/c Mice to Subcutaneously Injected Multi-Walled Carbon Nanotubes.” Nanotoxicology 5 (4): 583–591. doi:10.3109/17435390.2010.523483
   PubMed Web of Science ®Google Scholar
• Moghimi, S. M., and D. Simberg. 2017. “Complement Activation Turnover on Surfaces of Nanoparticles.” Nano Today 15: 8–10. doi:10.1016/j.nantod.2017.03.001
   PubMed Web of Science ®Google Scholar
• Moore, T. L., L. Rodriguez-Lorenzo, V. Hirsch, S. Balog, D. Urban, C. Jud, B. Rothen-Rutishauser, M. Lattuada, and A. Petri-Fink. 2015. “Nanoparticle Colloidal Stability in Cell Culture Media and Impact on Cellular Interactions.” Chemical Society Reviews 44 (17): 6287–6305. doi:10.1039/C4CS00487F
   PubMed Web of Science ®Google Scholar
• Mühlebach, S., G. Borchard, and S. Yildiz. 2015. “Regulatory Challenges and Approaches to Characterize Nanomedicines and Their Follow-on Similars.” Nanomed 10 (4): 659–674. doi:10.2217/nnm.14.189
   PubMed Web of Science ®Google Scholar
• Nair, A. B., and S. Jacob. 2016. “A Simple Practice Guide for Dose Conversion between Animals and Human.” Journal of Basic and Clinical Pharmacy 7 (2): 27–31. doi:10.4103/0976-0105.177703
   PubMedGoogle Scholar
• Navya, P. N., and H. K. Daima. 2016. “Rational Engineering of Physicochemical Properties of Nanomaterials for Biomedical Applications with Nanotoxicological Perspectives.” Nano Converg 3 (1): 1. doi:10.1186/s40580-016-0064-z
   PubMedGoogle Scholar
• Neagu, M., Z. Piperigkou, K. Karamanou, A. B. Engin, A. O. Docea, C. Constantin, C. Negrei, D. Nikitovic, and A. Tsatsakis. 2017. “Protein Bio-Corona: critical Issue in Immune Nanotoxicology.” Archives of Toxicology 91 (3): 1031–1048. doi:10.1007/s00204-016-1797-5
   PubMed Web of Science ®Google Scholar
• Nel, A., T. Xia, L. Mädler, and N. Li. 2006. “Toxic Potential of Materials at the Nanolevel.” Science 311 (5761): 622–627. doi:10.1126/science.1114397
   PubMed Web of Science ®Google Scholar
• Nemmar, A., P. Yuvaraju, S. Beegam, J. Yasin, E. E. Kazzam, and B. H. Ali. 2016. “Oxidative Stress, Inflammation, and DNA Damage in Multiple Organs of Mice Acutely Exposed to Amorphous Silica Nanoparticles.” International Journal of Nanomedicine 11: 919–928. doi:10.2147/IJN.S92278
   PubMed Web of Science ®Google Scholar
• NSCT/CoT/NSET. 2014. “2014 NNI Strategic Plan | Nano.” [WWW Document]. Accessed August 23 2017. https://www.nano.gov/node/1113
   Google Scholar
• Oberdörster, G. 2010. “Safety Assessment for Nanotechnology and Nanomedicine: concepts of Nanotoxicology.” Journal of Internal Medicine 267 (1): 89–105. doi:10.1111/j.1365-2796.2009.02187.x
   PubMed Web of Science ®Google Scholar
• Oberdörster, G., V. Stone, and K. Donaldson. 2007. “Toxicology of Nanoparticles: A Historical Perspective.” Nanotoxicology 1 (1): 2–25. doi:10.1080/17435390701314761
   Web of Science ®Google Scholar
• Oh, N., and J.-H. Park. 2014. “Endocytosis and Exocytosis of Nanoparticles in Mammalian Cells.” International Journal of Nanomedicine 9: 51–63. doi:10.2147/IJN.S26592
   PubMed Web of Science ®Google Scholar
• Oomen, A. G., E. A. J. Bleeker, P. M. J. Bos, F. van Broekhuizen, S. Gottardo, M. Groenewold, D. Hristozov, K. Hund-Rinke, M.-A. Irfan, A. Marcomini, et al. 2015. “Grouping and Read-across Approaches for Risk Assessment of Nanomaterials.” International Journal of Environmental Research and Public Health 12 (10): 13415–13434. doi:10.3390/ijerph121013415
   PubMed Web of Science ®Google Scholar
• Panchal, J., J. Kotarek, E. Marszal, and E. M. Topp. 2014. “Analyzing Subvisible Particles in Protein Drug Products: A Comparison of Dynamic Light Scattering (DLS) and Resonant Mass Measurement (RMM).” The AAPS Journal 16 (3): 440–451. doi:10.1208/s12248-014-9579-6
   PubMed Web of Science ®Google Scholar
• Park, J.-B. 2003. “Phagocytosis Induces Superoxide Formation and Apoptosis in Macrophages.” Experimental & Molecular Medicine 35 (5): 325–335. doi:10.1038/emm.2003.44
   PubMed Web of Science ®Google Scholar
• Park, M. V. D. Z., A. M. Neigh, J. P. Vermeulen, L. J. J. de la Fonteyne, H. W. Verharen, J. J. Briedé, H. van Loveren, and W. H. de Jong. 2011. “The Effect of Particle Size on the Cytotoxicity, Inflammation, Developmental Toxicity and Genotoxicity of Silver Nanoparticles.” Biomaterials 32 (36): 9810–9817. doi:10.1016/j.biomaterials.2011.08.085
   PubMed Web of Science ®Google Scholar
• Pelaz, B., C. Alexiou, R. A. Alvarez-Puebla, F. Alves, A. M. Andrews, S. Ashraf, L. P. Balogh, L. Ballerini, A. Bestetti, C. Brendel, et al. 2017. “Diverse Applications of Nanomedicine.” ACS Nano 11 (3): 2313–2381. doi:10.1021/acsnano.6b06040
   PubMed Web of Science ®Google Scholar
• Potočnik, J. 2011. “Commission Recommendation of 18 October 2011 on the Definition Of Nanomaterial 2011/696/EU.” Accessed 28 August 2017. https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32011H0696
   Google Scholar
• Puri, A., K. Loomis, B. Smith, J.-H. Lee, A. Yavlovich, E. Heldman, and R. Blumenthal. 2009. “Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic.” Critical Reviews in Therapeutic Drug Carrier Systems 26 (6): 523–580. doi:10.1615/CritRevTherDrugCarrierSyst.v26.i6.10
   PubMed Web of Science ®Google Scholar
• Pyrz, W. D., and D. J. Buttrey. 2008. “Particle Size Determination Using TEM: A Discussion of Image Acquisition and Analysis for the Novice Microscopist.” Langmuir 24 (20): 11350–11360. doi:10.1021/la801367j
   PubMed Web of Science ®Google Scholar
• Rao, A., M. Schoenenberger, E. Gnecco, T. Glatzel, E. Meyer, D. Brändlin, and L. Scandella. 2007. “Characterization of Nanoparticles Using Atomic Force Microscopy.” Journal of Physics: Conference Series 61: 971. doi:10.1088/1742-6596/61/1/192
   Google Scholar
• Roberson, S., and G. J. Weltje. 2014. “Inter-Instrument Comparison of Particle-Size Analysers.” Sedimentology 61 (4): 1157–1174. doi:10.1111/sed.12093
   Web of Science ®Google Scholar
• Robertson, J. D., L. Rizzello, M. Avila-Olias, J. Gaitzsch, C. Contini, M. S. Magoń, S. A. Renshaw, and G. Battaglia. 2016. “Purification of Nanoparticles by Size and Shape.” Scientific Reports 6 (1): 27494. doi:10.1038/srep27494
   PubMedGoogle Scholar
• Ros, P. R., P. C. Freeny, S. E. Harms, S. E. Seltzer, P. L. Davis, T. W. Chan, A. E. Stillman, L. R. Muroff, V. M. Runge, and M. A. Nissenbaum. 1995. “Hepatic MR Imaging with Ferumoxides: A Multicenter Clinical Trial of the Safety and Efficacy in the Detection of Focal Hepatic Lesions.” Radiology 196 (2): 481–488. doi:10.1148/radiology.196.2.7617864
   PubMed Web of Science ®Google Scholar
• Sabella, S. R. P. Carney, V. Brunetti, M. A. Malvindi, N. Al-Juffali, G. Vecchio, S. M. Janes, O. M. Bakr, R. Cingolani, F. Stellacci, and P. P. Pompa. 2014. “A General Mechanism for Intracellular Toxicity of Metal-Containing Nanoparticles.” [†Electronic Supplementary Information (ESI) available. See doi:10.1039/c4nr01234h Click here for additional data file.] Nanoscale 6: 7052–7061.
   Google Scholar
• Saraiva, C., C. Praça, R. Ferreira, T. Santos, L. Ferreira, and L. Bernardino. 2016. “Nanoparticle-Mediated Brain Drug Delivery: Overcoming Blood–Brain Barrier to Treat Neurodegenerative Diseases.” Journal of Controlled Release 235: 34–47. doi:10.1016/j.jconrel.2016.05.044
   PubMed Web of Science ®Google Scholar
• Sayes, C. M., N. Banerjee, and A. A. Romoser. 2009. “The Role of Oxidative Stress in Nanotoxicology.”In General, Applied and Systems Toxicology, edited by B. Ballantyne, T. C. Marrs, T. Syversen, D. A. Casciano and S. C. Sahu. Hoboken, New Jersey: John Wiley & Sons, Ltd. doi:10.1002/9780470744307.gat245
   Google Scholar
• Sayes, C. M., P. A. Smith, and I. V. Ivanov. 2013. “A Framework for Grouping Nanoparticles Based on Their Measurable Characteristics.” International Journal of Nanomedicine 8: 45–56. doi:10.2147/IJN.S40521
   PubMed Web of Science ®Google Scholar
• Scott-Fordsmand, J. J., S. Pozzi-Mucelli, L. Tran, K. Aschberger, S. Sabella, U. Vogel, C. Poland, D. Balharry, T. Fernandes, S. Gottardo, et al. 2014. “A Unified Framework for Nanosafety Is Needed.” Nano Today 9 (5): 546–549. doi:10.1016/j.nantod.2014.07.001
   Web of Science ®Google Scholar
• Seaton, A., L. Tran, R. Aitken, and K. Donaldson. 2010. “Nanoparticles, Human Health Hazard and Regulation.” Journal of the Royal Society Interface 7 (Suppl_1): S119–S129. doi:10.1098/rsif.2009.0252.focus
   PubMedGoogle Scholar
• Serpone, N., and S. Horikoshi. 2013. “Microwaves in Nanoparticle Synthesis: Fundamentals and Applications.” [WWW Document]. Accessed August 28 2017. http://www.wiley.com/WileyCDA/WileyTitle/productCd-3527331972.html
   Google Scholar
• Shannahan, J. 2017. “The Biocorona: A Challenge for the Biomedical Application of Nanoparticles.” Nanotechnology Reviews 6: 345–353. doi:10.1515/ntrev-2016-0098
   PubMed Web of Science ®Google Scholar
• Shimizu, K., H. Nakamura, and S. Watano. 2016. “MD Simulation Study of Direct Permeation of a Nanoparticle across the Cell Membrane under an External Electric Field.” Nanoscale 8 (23): 11897–11906. doi:10.1039/C6NR02051H
   PubMed Web of Science ®Google Scholar
• Shvedova, A. A., V. E. Kagan, and B. Fadeel. 2010. “Close Encounters of the Small Kind: adverse Effects of Man-Made Materials Interfacing with the Nano-Cosmos of Biological Systems.” Annual Review of Pharmacology and Toxicology 50 (1): 63–88. doi:10.1146/annurev.pharmtox.010909.105819
   PubMedGoogle Scholar
• Siegrist, S., H. Kettiger, E. Fasler-Kan, and J. Huwyler. 2017. “Selective Stimulation of the JAK/STAT Signaling Pathway by Silica Nanoparticles in Human Endothelial Cells.” Toxicology In Vitro 42: 308–318. doi:10.1016/j.tiv.2017.05.002
   PubMed Web of Science ®Google Scholar
• Simkó, M., D. Nosske, and W. G. Kreyling. 2014. “Metrics, Dose, and Dose Concept: The Need for a Proper Dose Concept in the Risk Assessment of Nanoparticles.” International Journal of Environmental Research and Public Health 11 (4): 4026–4048. doi:10.3390/ijerph110404026
   PubMed Web of Science ®Google Scholar
• Simkó, M., S. Tischler, and M.-O. Mattsson. 2015. “Pooling and Analysis of Published in Vitro Data: A Proof of Concept Study for the Grouping of Nanoparticles.” International Journal of Molecular Sciences 16 (11): 26211–26236. doi:10.3390/ijms161125954
   PubMed Web of Science ®Google Scholar
• Singh, A. K. 2015. Engineered Nanoparticles: Structure, Properties and Mechanisms of Toxicity. Cambridge, Massachusetts: Academic Press.
   Google Scholar
• Singh, N., G. J. Jenkins, R. Asadi, and S. H. Doak. 2010. “Potential Toxicity of Superparamagnetic Iron Oxide Nanoparticles (SPION).” Nano Rev 1 (1): 5358. doi:10.3402/nano.v1i0.5358
   PubMedGoogle Scholar
• Stone, V., S. Pozzi-Mucelli, L. Tran, K. Aschberger, S. Sabella, U. Vogel, C. Poland, D. Balharry, T. Fernandes, S. Gottardo, et al. 2014. “ITS-NANO - Prioritising Nanosafety Research to Develop a Stakeholder Driven Intelligent Testing Strategy.” Particle and Fibre Toxicology 11 (1): 9. doi:10.1186/1743-8977-11-9
   PubMedGoogle Scholar
• Szebeni, J., S. Fishbane, M. Hedenus, S. Howaldt, F. Locatelli, S. Patni, D. Rampton, G. Weiss, and J. Folkersen. 2015. “Hypersensitivity to Intravenous Iron: classification, Terminology, Mechanisms and Management.” British Journal of Pharmacology 172 (21): 5025–5036. doi:10.1111/bph.13268
   PubMed Web of Science ®Google Scholar
• Tämm, K., L. Sikk, J. Burk, R. Rallo, S. Pokhrel, L. Mädler, J. J. Scott-Fordsmand, P. Burk, and T. Tamm. 2016. “Parametrization of Nanoparticles: development of Full-Particle Nanodescriptors.” Nanoscale 8 (36): 16243–16250. doi:10.1039/C6NR04376C
   PubMed Web of Science ®Google Scholar
• Teeguarden, J. G., P. M. Hinderliter, G. Orr, B. D. Thrall, and J. G. Pounds. 2007. “Particokinetics in Vitro: dosimetry Considerations for in Vitro Nanoparticle Toxicity Assessments.” Toxicological Sciences 95 (2): 300–312. doi:10.1093/toxsci/kfl165
   PubMed Web of Science ®Google Scholar
• Tiwari, D., J. Takashi, and J. Behari. 2010. “Dose-Dependent In-Vivo Toxicity Assessment of Nanoparticle in Wistar Rats.” Toxicology Mechanisms and Methods 21 (1): 13–24. doi:10.3109/15376516.2010.529184
   PubMed Web of Science ®Google Scholar
• Toy, R., L. Bauer, C. Hoimes, K. B. Ghaghada, and E. Karathanasis. 2014. “Targeted Nanotechnology for Cancer Imaging.” Advanced Drug Delivery Reviews 76: 79–97. doi:10.1016/j.addr.2014.08.002
   PubMed Web of Science ®Google Scholar
• Treuel, L., D. Docter, M. Maskos, and R. H. Stauber. 2015. “Protein Corona – from Molecular Adsorption to Physiological Complexity.” Beilstein Journal of Nanotechnology 6: 857–873. doi:10.3762/bjnano.6.88
   PubMed Web of Science ®Google Scholar
• Turner, P. V., T. Brabb, C. Pekow, and M. A. Vasbinder. 2011. “Administration of Substances to Laboratory Animals: Routes of Administration and Factors to Consider.” Journal of the American Association for Laboratory Animal Science 50 (5): 600–613.
   PubMed Web of Science ®Google Scholar
• Unfried, K., C. Albrecht, L.-O. Klotz, A. Von Mikecz, S Grether-Beck, R.P.F. Schins. 2007. “Cellular responses to nanoparticles: Target structures and mechanisms.” Nanotoxicology 1: 52–71. doi:10.1080/00222930701314932
   Web of Science ®Google Scholar
• Unterweger, H., C. Janko, M. Schwarz, L. Dézsi, R. Urbanics, J. Matuszak, E. Őrfi, T. Fülöp, T. Bäuerle, J. Szebeni. et al. 2017. “Non-Immunogenic Dextran-Coated Superparamagnetic Iron Oxide Nanoparticles: A Biocompatible, Size-Tunable Contrast Agent for Magnetic Resonance Imaging.” International Journal of Nanomedicine 12: 5223–5238. doi:10.2147/IJN.S138108
   PubMed Web of Science ®Google Scholar
• Uskoković, V. 2013. “Entering the Era of Nanoscience: Time to Be so Small.” Journal of Biomedical Nanotechnology 9 (9): 1441–1470. doi:10.1166/jbn.2013.1642
   PubMed Web of Science ®Google Scholar
• van Teunenbroek, T. 2017. “NANoREG, A Common European Approach to the Regulatory Testing of Nanomaterials.” [WWW Document]. www.nanoreg.eu. Accessed December 21 2017. http://www.rivm.nl/en/About_RIVM/Mission_and_strategy/International_Affairs/International_Projects/Completed/NANoREG/NANoREG_Results_Repository_sub_page_Final_Report
   Google Scholar
• Verhoef, J. J., and T. J. Anchordoquy. 2013. “Questioning the Use of PEGylation for Drug Delivery. Drug Deliv.” Drug Delivery and Translational Research 3 (6): 499–503. doi:10.1007/s13346-013-0176-5
   PubMed Web of Science ®Google Scholar
• Vermeij, E. A., M. I. Koenders, M. B. Bennink, L. A. Crowe, L. Maurizi, J.-P. Vallée, H. Hofmann, W. B. Berg, L. van den, P. L. E. M. van, Loo, and F. A. J. van de. 2015. “The in-Vivo Use of Superparamagnetic Iron Oxide Nanoparticles to Detect Inflammation Elicits a Cytokine Response but Does Not Aggravate Experimental Arthritis.” PLoS One 10 (5): e0126687. doi:10.1371/journal.pone.0126687
   PubMed Web of Science ®Google Scholar
• Vetten, M. A., C. S. Yah, T. Singh, and M. Gulumian. 2014. “Challenges Facing Sterilization and Depyrogenation of Nanoparticles: effects on Structural Stability and Biomedical Applications.” Nanomedicine: Nanotechnology, Biology, and Medicine 10 (7): 1391–1399. doi:10.1016/j.nano.2014.03.017
   PubMed Web of Science ®Google Scholar
• Vippola, M., M. Valkonen, E. Sarlin, M. Honkanen, and H. Huttunen. 2016. “Insight to Nanoparticle Size Analysis—Novel and Convenient Image Analysis Method versus Conventional Techniques.” Nanoscale Research Letters 11 (1): 169. doi:10.1186/s11671-016-1391-z
   PubMedGoogle Scholar
• Weinstein, J. S., C. G. Varallyay, E. Dosa, S. Gahramanov, B. Hamilton, W. D. Rooney, L. L. Muldoon, and E. A. Neuwelt. 2010. “Superparamagnetic Iron Oxide Nanoparticles: diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, A Review.” Journal of Cerebral Blood Flow & Metabolism 30 (1): 15–35. doi:10.1038/jcbfm.2009.192
   PubMed Web of Science ®Google Scholar
• Weissig, V., T. K. Pettinger, and N. Murdock. 2014. “Nanopharmaceuticals (Part 1): Products on the Market.” International Journal of Nanomedicine 9: 4357–4373. doi:10.2147/IJN.S46900
   PubMed Web of Science ®Google Scholar
• Weissleder, R., M. Nahrendorf, and M. J. Pittet. 2014. “Imaging Macrophages with Nanoparticles.” Nature Materials 13 (2): 125–138. doi:10.1038/nmat3780
   PubMed Web of Science ®Google Scholar
• Wen, H., M. Dan, Y. Yang, J. Lyu, A. Shao, X. Cheng, L. Chen, and L. Xu. 2017. “Acute Toxicity and Genotoxicity of Silver Nanoparticle in Rats.” PLoS One 12 (9): e0185554. doi:10.1371/journal.pone.0185554
   PubMed Web of Science ®Google Scholar
• Whitesides, G. M. 2003. “The “Right” Size in Nanobiotechnology.” Nature Biotechnology 21 (10): 1161–1165. doi:10.1038/nbt872
   PubMed Web of Science ®Google Scholar
• Witzigmann, D., M. Camblin, J. Huwyler, and V. Balasubramanian. 2015. “Nanomaterials: Therapeutic Applications.”In The Encyclopedia of Biomedical Polymers & Polymeric Biomaterials, edited by M. Mishra, 5364–5378. New York: Taylor & Francis.
   Google Scholar
• Wolfram, J., M. Zhu, Y. Yang, J. Shen, E. Gentile, D. Paolino, M. Fresta, G. Nie, C. Chen, H. Shen. et al. 2015. “Safety of Nanoparticles in Medicine.” Current Drug Targets 16 (14): 1671–1681. doi:10.2174/1389450115666140804124808
   PubMed Web of Science ®Google Scholar
• Wu, X., Z.-R. Lu. 2016. “Nanoparticle–Tissue Interaction..” In Nanomaterials in Pharmacology. Methods in Pharmacology and Toxicology, edited by Z.-R. Lu, S. Sakuma, 201–218. New York, NY: Humana Press. doi:10.1007/978-1-4939-3121-7
   Google Scholar
• Xie, J., S. Lee, and X. Chen. 2010. “Nanoparticle-Based Theranostic Agents.” Advanced Drug Delivery Reviews 62 (11): 1064–1079. doi:10.1016/j.addr.2010.07.009
   PubMed Web of Science ®Google Scholar
• Yameen, B., W. I. Choi, C. Vilos, A. Swami, J. Shi, and O. C. Farokhzad. 2014. “Insight into Nanoparticle Cellular Uptake and Intracellular Targeting.” 30th Anniversary Special Issue 190: 485–499. doi:10.1016/j.jconrel.2014.06.038
   Google Scholar
• Yang, Y., Z. Qin, W. Zeng, T. Yang, Y. Cao, C. Mei, and Y. Kuang. 2017. “Toxicity Assessment of Nanoparticles in Various Systems and Organs.” Nanotechnology Reviews 6: 279. doi:10.1515/ntrev-2016-0047
   Web of Science ®Google Scholar
• Yildirimer, L., N. T. K. Thanh, M. Loizidou, and A. M. Seifalian. 2011. “Toxicology and Clinical Potential of Nanoparticles.” Nano Today 6 (6): 585–607. doi:10.1016/j.nantod.2011.10.001
   PubMed Web of Science ®Google Scholar
• Yuan, S. Y., and R. R. Rigor. 2010. The Endothelial Barrier. San Rafael, California: Morgan & Claypool Life Sciences.
   Google Scholar
• Zaloga, J., C. Janko, J. Nowak, J. Matuszak, S. Knaup, D. Eberbeck, R. Tietze, H. Unterweger, R. P. Friedrich, S Duerr, et al. 2014. “Development of a Lauric Acid/Albumin Hybrid Iron Oxide Nanoparticle System with Improved Biocompatibility.” International Journal of Nanomedicine 9: 4847–4866. doi:10.2147/IJN.S68539
   PubMed Web of Science ®Google Scholar
• Zhang, H., Z. Ji, T. Xia, H. Meng, C. Low-Kam, R. Liu, S. Pokhrel, S. Lin, X. Wang, Y.-P. Liao, et al. 2012. “Use of Metal Oxide Nanoparticle Band Gap to Develop a Predictive Paradigm for Oxidative Stress and Acute Pulmonary Inflammation.” ACS Nano 6 (5): 4349–4368. doi:10.1021/nn3010087
   PubMed Web of Science ®Google Scholar
• Zhang, S., J. Li, G. Lykotrafitis, G. Bao, and S. Suresh. 2009. “Size-Dependent Endocytosis of Nanoparticles.” Advanced Materials 21 (4): 419–424. doi:10.1002/adma.200801393
   PubMed Web of Science ®Google Scholar
• Zhao, L., A. Seth, N. Wibowo, C.-X. Zhao, N. Mitter, C. Yu, and A. P. J. Middelberg. 2014. “Nanoparticle Vaccines.” Vaccine 32 (3): 327–337. doi:10.1016/j.vaccine.2013.11.069
   PubMed Web of Science ®Google Scholar
• Zheng, J., J. D. Clogston, A. K. Patri, M. A. Dobrovolskaia, and S. E. McNeil. 2011. “Sterilization of Silver Nanoparticles Using Standard Gamma Irradiation Procedure Affects Particle Integrity and Biocompatibility.” Journal of Nanomedicine & Nanotechnology S5 (01): 001. doi:10.4172/2157-7439.S5-001
   Google Scholar